Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
Go back to Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 0.65 +0.01 (1.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.64 | 52 Week High | $9.58 | |||
| Open | $0.64 | 52 Week Low | $2.34 | |||
| Day High | $0.65 | P/E | N/A | |||
| Day Low | $0.62 | EPS | $-0.34 | |||
| Volume | 263,042 | |||||
